Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration
- PMID: 12200623
- DOI: 10.1007/s00401-002-0565-1
Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration
Abstract
The major component of Alzheimer's disease (AD) neurofibrillary tangles (NFTs) is abnormally hyperphosphorylated tau aggregated as paired helical filaments (PHFs). Cell division cycle (cdc) 2 kinase is one of the main candidate kinases that phosphorylates normal tau in vitro at several sites seen in PHF-tau. Using brains staged according to Braak and Braak criteria, we investigated the role of cdc2 in neurofibrillary changes in the hippocampal formation, and the entorhinal and temporal cortices. Neurons with tangle-like inclusions positive for active cdc2 were found to appear first in the Pre-alpha layer of the entorhinal cortex, and then extend to other brain regions co-incident with the progressive sequence of neurofibrillary changes. This predictable progressive pattern is not associated with amyloid. The intraneuronal accumulation of active cdc2 appeared to precede the deposition of PHF-tau phosphorylated at Ser 202/Thr 205 sites. These data are consistent with the notion that cdc2 might be involved in the abnormal hyperphosphorylation of tau and consequently aggregation of tau into PHF at an early stage and that increased cdc2 activity is not consequent to the deposition of beta-amyloid in AD brain.
Similar articles
-
Role of protein kinase B in Alzheimer's neurofibrillary pathology.Acta Neuropathol. 2003 Apr;105(4):381-92. doi: 10.1007/s00401-002-0657-y. Epub 2002 Dec 18. Acta Neuropathol. 2003. PMID: 12624792
-
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13. Acta Neuropathol. 2002. PMID: 12410379
-
Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.Brain Res. 2008 Jun 5;1213:152-65. doi: 10.1016/j.brainres.2008.03.043. Epub 2008 Apr 1. Brain Res. 2008. PMID: 18455153
-
Neurofibrillary pathology and aluminum in Alzheimer's disease.Histol Histopathol. 1995 Oct;10(4):969-78. Histol Histopathol. 1995. PMID: 8574016 Review.
-
Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.Arzneimittelforschung. 1995 Mar;45(3A):403-9. Arzneimittelforschung. 1995. PMID: 7763334 Review.
Cited by
-
Model scenarios for cell cycle re-entry in Alzheimer's disease.iScience. 2022 Jun 7;25(7):104543. doi: 10.1016/j.isci.2022.104543. eCollection 2022 Jul 15. iScience. 2022. PMID: 35747391 Free PMC article.
-
Core cell cycle machinery is crucially involved in both life and death of post-mitotic neurons.Cell Mol Life Sci. 2020 Nov;77(22):4553-4571. doi: 10.1007/s00018-020-03548-1. Epub 2020 May 31. Cell Mol Life Sci. 2020. PMID: 32476056 Free PMC article. Review.
-
Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer's Disease and Brain Insulin Resistance, and Its Relation to Cancer.J Alzheimers Dis. 2019;67(1):1-11. doi: 10.3233/JAD-180874. J Alzheimers Dis. 2019. PMID: 30452418 Free PMC article. Review.
-
Genetic and pharmacological inhibition of Cdk1 provides neuroprotection towards ischemic neuronal death.Cell Death Discov. 2018 Mar 16;4:43. doi: 10.1038/s41420-018-0044-7. eCollection 2018. Cell Death Discov. 2018. PMID: 29581894 Free PMC article.
-
Neuronal cell cycle: the neuron itself and its circumstances.Cell Cycle. 2015;14(5):712-20. doi: 10.1080/15384101.2015.1004937. Cell Cycle. 2015. PMID: 25590687 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
